CARLOS ARTEAGA MÜLLER

ACTUAL POSITIONSenior Consultant. Department of Urology.Complejo Hospitalario Universitario de Ourense. Ourense. SpainFunctional and Reconstructive Urology Unit Director at ComplejoHospitalarioUniversitario de OurenseHead of Urology Service at Centro Medico El Carmen EDUCATION1997 Medical degree.Universidad Central de Venezuela. Venezuela.(Approved the corresponding Spanish degree -2002- ).Recognition Excellence Awards:Magna Cum Laude MentionAward “Campins y Ballester” to Student excellence. 2001 Residency in General Surgery.Hospital Vargas de Caracas. Central University of Venezuela.Head of residents 2000-2001Student Excellence Scholarship. Cientific and Humanistic Council. Universidad Central de Venezuela. 2008 Residency in Urology. UrologyDepartment. Hospital Clínico Universitario de Valladolid.Spain. 2010 UrodynamicsAcreditation.International Continence Society (ICS) Urodynamics School. 2011 FEBU – Fellow European Board of Urology. Union Européenne des MédecinsSpécialistes U.E.M.S 2016 PhD.Surgery Department. Universidad de Salamanca. SpainRecognition award: Cum laude plus. Clinical SKILLS AND experience Urinary incontinence. Male and female.Urodynamics and Functional Urology.Urogynaecologic proccedures. Pelvic organ prolapse.Reconstructive Urology: Urethral Stricture, Diverticulum, Peyronies Disease, OncologyEndoscopic and open surgery. General urologyProstate biopsies and minor surgical tecniques.Experience in Creation and Development of Urologic Unit in a Urologic Department UROLOGY WORK EXPERIENCE2008 - 2013 Consultant Urologist. Hospital Povisa. Vigo. Spain (Joint Comission Hospital) Urodynamic and Functional Urology Unit PREVIOUS WORK EXPERIENCE· PrivatePractice. General Surgery. Hospital de Clínicas Caracas. Caracas. Venezuela.· General Medical Director. Alcadía Miranda State . Rio Chico, Venezuela. 1998 2001-2002.· General Medical hospital "Regener Ernesto", Rio Chico, Edo. Miranda. Venezuela. 1997-1998. MANAGEMENT· Practical Keys on Medical Management. IESE Business School. Madrid. Spain.2013 y 2015 SCIENTIFIC SOCIETIES AFFILIATIONS· European Association of Urology (EAU)· International ContinenceSociety (ICS)· Sociedad Iberoamericana de Neurourologia y Uroginecologia (SINUG)· Asociación española de Urología (AEU)(UrologySpanishAssociation)· Sociedad gallega de Urología. (GalicianUrologyAssociation)o Junta Directiva. Vocal. 2013-2014· Asociación Continentia (ContinencesSociety) TEACHING EXPERIENCE· Master of Urological Nursing. Professor of Oncological Urology. Alcalá de Henares University. Spain· Predoctoral Advises – Trainning in Functional urology and Urodynamics Dr Raul Calvo Gonzalez – (Urodynamic rotation) 2012 Clinical Universitary Hospital of ValladolidUrology Service.Actually Urologist in Universittary Hospital of Valladolid Dr. Jacobo Freire (Urodynamic rotation ) 2013 Hospital Universitario de Vigo Urology Service Actually Urologist in University Hospital of Ourense Dra. Raquel Gonzalez (Urogynecology rotation ) 2011 Hospital Posivsa – vigo General Surgery Service· Undergraduate colaboratorin Department of Surgery, Ophtalmology, Otolaryngology and Physiotherapy. Valladolid University. 2003-04, 2004-05, 2005-06, 2006-07.· Undergraduate colaborator with Medical Students of Santiago de Compostela University. UrologyRotation JOURNAL REVIEWER · Actas Urológicas Españolas.FunctionalUrologySection.· TherapeuticAdvance in Urology BOOKS CHAPTERSSemiotics of Urologic Diseases. In: Manual of General Urology. Fernández del Busto, E. Universidad de Valladolid. Secretariado de Publicaciones. 2004.Haematuria. In: Practical Manual of Diagnosys and Treatment in Medicine. Hospital Clínico Universitario de Valladolid. Sacyl. JOURNAL PUBLICATIONSPascual Samaniego, M.; Calleja Escudero, J.; Alvarez Gago, T.; Gonzalo Rodríguez, V.; Muller Arteaga, C.; Fernández del Busto, E.AdultWilms´ tumor. Actas Urol. Esp. 2004; 28(7): 544-8.Calleja Escudero, J.; Muller Arteaga, C.; Torrecilla García-Ripoll, J.; et al.Pelvic recurrence after radical Cystectomy for bladder cancer. Arch. Esp. Urol. 2005; 58(3): 258-61.Muller Arteaga, C.; Martin Blanco, S.; Calleja Escudero, J.; et al. Spontaneous hemorrhage and arterial hypertension as complication of Adrenal Pseudocyst. Report of a case.Actas Urol. Esp. 2005; 29(6): 599-602.Muller Arteaga, C.; Egea Camacho, J.; Alvarez Gago, T.; et al.Spermatic cord liposarcoma. Association with prostate cancer. Report of a case and review of literature. Actas Urol. Esp. 2005; 29(7): 700-3.Gonzalo Rodríguez, V.; Rivero Martínez, MD.; Trueba Arguiñarena, J.; Calleja Escudero, J.; Muller Arteaga, C; Fernández del Busto, E. Diagnosis and treatment of urologicalcomplications in kidneytransplants. Actas Urol. Esp. 2006; 30(6): 619-25.Torrecilla García-Ripoll, JR.; Muller Arteaga, C.; Sanz Ruiz, A.; et al. Renal hydatidosis.Arch. Esp. Urol. 2006; 59(7): 739-42.Martín Martín, S.; Torrecilla García-Ripoll, JR.; Sanz Ruíz, A.; Gonzalo Rodríguez, V.; Muller Arteaga, C.; Fernández del Busto, E. Genital traumatism. Actas Urol. Esp. 2007; 31(7): 800.Martín Martín, S.; Cortiñas González, JR.; Garcia Lagarto, E. Muller Arteaga, C.; Torrecilla García-Ripoll, JR.; Fernández del Busto, E. Primarysmallcell carcinoma of theureter. International Journal of Urology. 2007; 14: 771-3.Martin Martin, S.; Muller Arteaga, C.; Gonzalo Rodriguez, V.; et al. Vesical hemangioma. Actas Urol. Esp. 2007; 31(10): 1172-74.Muller Arteaga, C.; Martín Martín, S.; DeCastro Olmedo, C.; et al. Solitary skin metastasis from a bladder carcinoma. Arch. Esp. Urol. 2007; 60(10): 1215-18.Martin Martin, S.; Muller Arteaga, C.;Garcia Lagarto, E.; et al. Malignant fibrous histiocytoma of the spermatic cord. Presentation of one case and literature review.Actas Urol. Esp. 2008; 32 (7): 745-8.Martin Martin, S.; Muller Arteaga, C.; Garcia Lagarto, E.; et al. Squamous cell carcinoma in a duplicated renal pelvis after percutaneous nephrolithotomy.ArchEspUrol. 2008; 61(5): 633-6.Muller Arteaga, C.; Martín Martín, S.; Cortiñas Gonzalez, JR.; et al. Posterior nutcracker syndrome: retroaortic renal vein associated with arteriovenous fistula and renal cancinoma. Report of a case and review of literature. ActasUrol Esp. 2009; 33(1): 101-4.Leal D.; Fariña, L.; Pesqueira, D.; Meijide F.; Quintana, J.; Muller, C.; Regojo, J.; Anton ¡, I. Testicular EpydermoidCyst. Actas Urol Esp. 2010; 34(3): 274-7.Miembro del comité científico de Artículo: Esteban M, Castro DM. Pharmacological treatment of lower urinary tract symptoms in men: implementation of recommendations in clinical practice.Actas Urol Esp. 2013.Lavalle L. López-Fando, Cidre M.A. Jimenez, Fuertes M. Esteban, Martinez F.J. Llorens, Casado J. Salinas, Diaz D. Castro, Arteaga C. Müller, Zurbano J.M. Adot, Escobar F. Rodriguez, Garcia M.A. Bonillo, Patuel B. Madurga, Vallejo M. Leva, Cusi L. Peri, Sugrañes J. Conejero, Calvo J. Jiménez, IFU Group, Madrid, Spain. Psychometric validation of a 3-day bladder diary model for lower urinary tract symptoms. EuropeanUrologySupp. 2013. 12(1): e888-e889.B.Y. Padilla Fernandez, Á.J. Virseda Rodríguez, L.S. Valverde Martínez, B.J. Pereira, H. Coelho, M. Montesino Semper, C. Müller Arteaga, J.L. Álvarez-Ossorio Fernández, F. Migliorini, M.T. Santos Antunes, A. Lorenzo Gómez, M.B. García Cenador, P. Antúnez Plaza, M.F. Lorenzo Gómez. Relantionship between tumor burden in the transrectal biopsy and positive margins in radical prostatectomy.EuropeanUrologySupp. 2014. 13(5): 130-13.B.Y. Padilla Fernandez, Á.J. Virseda Rodríguez, B.J. Pereira, H. Coelho, M. Montesino Semper, C. Müller Arteaga, J.L. Álvarez-Ossorio Fernández, F. Migliorini, M.T García Cenador, P. Antunes Plaza, J.M. Silva Abuin. A. Santos Lorenzo Gómez, M.T. Santos, M.F. Lorenzo Gómez. Factors related with urinary incontinence grade after radical prostatectomy. European Urology Supp. 2014. 13(5): 125.19. Jiménez Cidre, M.A.; López-Fando Lavalle, L.; Esteban Fuertes, M.; Prieto Chaparro L.; Llorens Martinez, F.J.; Salinas Casado, J.; Castro Diaz, D.; Müller Arteaga, C; Adot Zurbano, J.M. ; Gutierrez Ruiz ,C.; Rodriguez Escobar, F.; Arlandis Guzman, S.; Bonillo Garcia, M.A.; Madurga Patuel, B.; Leva Vallejo, M.; Franco de Castro , A.; Peri Cusi, L.; Conejero Sugrañes, J.; Jiménez Calvo, J.The 3-Day BladderDiaryis a feasible, reliable and validtool to evaluatethelowerurinarytractSymptoms in women.NeurourolUrodyn. 2015; 34(2): 128-32.20. Barbara Padilla Fernandez, Carlos Müller Arteaga, AlvaroVirseda Rodriguez, Juan Nuñez Otero, Miguel AdriazolaSemino, Miguel GarciaGarcia, Maria F Lorenzo Gomez. Long-term efficacy of the treatment with intravesical chondroitin sulphate in women with painful bladder syndrome/intersticial cystitis. Maturitas. 2015; 81: 20521. Carlos Muller-Arteaga, Salvador Arlandis Guzmán, María Fernanda Lorenzo Gómez, Carlos Errando-Smet, Raquel González López, Javier Cambronero Santos, José Luis Gutiérrez Baños, Manuel Sánchez Marcos, Antonio Ortiz Gamiz, Sergio Merino Salas, Roberto Martínez Rodríguez, Iván Olano Grasa. Expert opinion about the use of transdermic oxybutynin in Spain for the treatment of adult overactive bladder.ArchEspUrol. 2016; 69(9): 613-620 CONCENSUS DOCUMENTS (Guidelines)· Consensus document of the Spanish Association of Urology in the management of uncomplicated recurrent urinary tract infections. Actas UrolEsp 2015; 39(6):339-348.· OnabotulinumtoxinA in Overactive Bladder: Consensus Recommendations Based on Evidence.Grupo ALLURA. Actas UrolEsp 2015. INVESTIGATIONS/ FINANCIAL WORKS Clean Intermitent selfcatheter Patient Profile in SpainOVERACTIVE BLADDER IN OLDER PATIENT Study GroupCognitive Impairment with Antimuscarinic treatmentMALES Project- Astella PharmaSTUI in males. Clinical cases selection. Prospective studyInvestigator Member (Grupo IFU) (Investigation group) Grupo de Investigación de Resultados en Salud en Urología funcional y Urodinámica Patrocinado por Astellas Pharma. • “Estudio de evaluación de la Vejiga Idiopática de la mujer en unidades de Urología Funcional y Urodinámica” Evaluation of idiophatic bladder in functional and urodynamics units•“Evaluación de la Urgencia miccional en mujeres con Vejiga Hiperactiva Idiopática de la mujer en unidades de Urología Funcional y Urodinámica” Evaluation of miccional urgency in women in functional and urodynamics units•“ESTUDIO DM3D Estudio de Evaluación de la factibilidad, validez y fiabilidad del diario miccional de 3 días, en mujeres atendidas en Unidades de Urología Funcional y Urodinámica.”. Facts and fiability of 3 days bladder miccional diary in in functional and urodynamics units•Estudio de la Sintomatología del tracto urinario inferior en varones que acuden a las unidades de Urología Funcional y Urodinámica” Evaluation of lower urinary tract symtptoms in males in in functional and urodynamics units•Evaluación de pacientes con Sd dolor vesical. Evaluation of patients with bladder pain syndrome UROCOR Study. “Estudio para valorar el impacto del tratamiento de bloqueo androgénico en la incidencia de alteraciones metabólicas en pacientes con cáncer de próstata”. Metabolic impact in patients with androgenic blockage for prostate cancer. Astrazeneca.EURCIS Study: Estudio del impacto de la sintomatología urinaria en la calidad de vida de los pacientes con cistitis intersticial, síndrome de dolor vesical y cistitis radioinducida”. Quality of life in bladder pain syndrome-intersticial cystitis patients. Lab Rubió.ANAMED .StudyTratamiento hormonal en pacientes con cáncer de próstata. Hormonal treatment in prostate cancer patients. Ipsen pharma.ANARESISTANCE Study. Tratamiento hormonal en pacientes con Ca de próstata. Hormonal treatment in prostate cancer patients. Investigador colaborador (Hospital Povisa). Ipsen Pharma (en desarrollo).SONDYPOOL Study. Calidad de vida en pacientes sometidos a autocateterismos. Quality of life in bladder autocatheterism patients. Braun. 2009.ORAL AND POSTER COMUNICATIONSMore tan 40 in National and International CongressCONGRESS ACTIVITIESRound table Coordinator, Speaker, Evaluator Poster, Live Surgery in National and International CongressCONTINUAL MEDICAL EDUCATIONI’ve asisted more than 100 courses of continual medical educationFOREIGN HELP ACTIVITIES Help Brigade to Nicaragüa. Cohen Foundation and Ipsen Pharma Program. 2011